Theoretical Insights into Provigil: A Cognitive Enhancer and Its Implications
Theoretical Insights into Provigil: A Cognitive Enhancer and Its Implications Provigil, generically referred to as modafinil, is a wakefulness-selling agent that was first approved by the U.S. Food and Drug Administration (FDA) in 1998 for the treatment of narcolepsy, a disorder characterized by excessive daytime sleepiness. Over the years, its utilization has expanded beyond prescribed medical contexts and into off-label use as a cognitive enhancer among healthy people, sp